These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2695356)
21. Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Jiang WY; Chattedee AD; Raychaudhuri SP; Raychaudhuri SK; Farber EM Int J Dermatol; 2001 Nov; 40(11):699-703. PubMed ID: 11737436 [TBL] [Abstract][Full Text] [Related]
22. Microdialysis documents changes in the micromilieu of psoriatic plaques under continuous systemic therapy. Salgo R; Thaçi D; Boehncke S; Diehl S; Hofmann M; Boehncke WH Exp Dermatol; 2011 Feb; 20(2):130-3. PubMed ID: 21255092 [TBL] [Abstract][Full Text] [Related]
23. Cellular retinoic acid- but not cellular retinol-binding protein is elevated in psoriatic plaques. Siegenthaler G; Saurat JH; Hotz R; Camenzind M; Merot Y J Invest Dermatol; 1986 Jan; 86(1):42-5. PubMed ID: 2427593 [TBL] [Abstract][Full Text] [Related]
24. Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis. Groves RW; Sherman L; Mizutani H; Dower SK; Kupper TS Am J Pathol; 1994 Nov; 145(5):1048-56. PubMed ID: 7977638 [TBL] [Abstract][Full Text] [Related]
25. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222 [TBL] [Abstract][Full Text] [Related]
26. Interleukin 2, soluble interleukin 2 receptor, and interferon-gamma in the suction blister fluids from psoriatic skin. Takematsu H; Tagami H Arch Dermatol Res; 1990; 282(3):149-52. PubMed ID: 2114831 [TBL] [Abstract][Full Text] [Related]
27. Interleukin-1 and interleukin-6 in psoriasis. Prens EP; Benne K; van Damme J; Bakkus M; Brakel K; Benner R; van Joost T J Invest Dermatol; 1990 Dec; 95(6 Suppl):121S-124S. PubMed ID: 2258628 [TBL] [Abstract][Full Text] [Related]
28. Differential expression of protein kinase C isoenzymes in normal and psoriatic adult human skin: reduced expression of protein kinase C-beta II in psoriasis. Fisher GJ; Tavakkol A; Leach K; Burns D; Basta P; Loomis C; Griffiths CE; Cooper KD; Reynolds NJ; Elder JT J Invest Dermatol; 1993 Oct; 101(4):553-9. PubMed ID: 8409523 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts. Konstantinova NV; Duong DM; Remenyik E; Hazarika P; Chuang A; Duvic M J Invest Dermatol; 1996 Oct; 107(4):615-21. PubMed ID: 8823370 [TBL] [Abstract][Full Text] [Related]
30. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine. Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379 [TBL] [Abstract][Full Text] [Related]
31. Noninvasive proteome analysis of psoriatic stratum corneum reflects pathophysiological pathways and is useful for drug profiling. Méhul B; Laffet G; Séraïdaris A; Russo L; Fogel P; Carlavan I; Pernin C; Andres P; Queille-Roussel C; Voegel JJ Br J Dermatol; 2017 Aug; 177(2):470-488. PubMed ID: 28129666 [TBL] [Abstract][Full Text] [Related]
32. The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris. Alessandrini F; Stachowitz S; Ring J; Behrendt H J Invest Dermatol; 2001 Mar; 116(3):394-400. PubMed ID: 11231313 [TBL] [Abstract][Full Text] [Related]
33. Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis. Anttila HS; Reitamo S; Erkko P; Ceska M; Moser B; Baggiolini M J Invest Dermatol; 1992 Jan; 98(1):96-101. PubMed ID: 1728643 [TBL] [Abstract][Full Text] [Related]
34. Enhanced production of biologically active interleukin-1 alpha and interleukin-1 beta by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1 beta levels and facilitated interleukin-1 release. Debets R; Hegmans JP; Troost RJ; Benner R; Prens EP Eur J Immunol; 1995 Jun; 25(6):1624-30. PubMed ID: 7614991 [TBL] [Abstract][Full Text] [Related]
35. IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids. Mussi A; Bonifati C; Carducci M; Viola M; Tomaselli R; Sacerdoti G; Fazio M; Ameglio F J Biol Regul Homeost Agents; 1994; 8(4):117-20. PubMed ID: 7660853 [TBL] [Abstract][Full Text] [Related]
36. Neutrophil chemoattractant and IL-1-like activity in samples from psoriatic skin lesions. Further characterization. Fincham NJ; Camp RD; Gearing AJ; Bird CR; Cunningham FM J Immunol; 1988 Jun; 140(12):4294-9. PubMed ID: 3286771 [TBL] [Abstract][Full Text] [Related]
37. Distribution of p230, an alpha-spectrin-related polypeptide in normal and psoriatic epidermis and in cultured human keratinocytes. Kariniemi AL; Lehto VP; Virtanen I Br J Dermatol; 1984 Aug; 111(2):139-45. PubMed ID: 6205675 [TBL] [Abstract][Full Text] [Related]
38. Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis. Raychaudhuri SP; Jiang WY; Farber EM; Schall TJ; Ruff MR; Pert CB Acta Derm Venereol; 1999 Jan; 79(1):9-11. PubMed ID: 10086850 [TBL] [Abstract][Full Text] [Related]
39. Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines. Funding AT; Johansen C; Kragballe K; Otkjaer K; Jensen UB; Madsen MW; Fjording MS; Finnemann J; Skak-Nielsen T; Paludan SR; Iversen L J Invest Dermatol; 2006 Aug; 126(8):1784-91. PubMed ID: 16543895 [TBL] [Abstract][Full Text] [Related]
40. Expression of interleukin-12 is increased in psoriatic skin. Yawalkar N; Karlen S; Hunger R; Brand CU; Braathen LR J Invest Dermatol; 1998 Dec; 111(6):1053-7. PubMed ID: 9856816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]